Early ADME in Support of Drug Discovery: The Role of Metabolic Stability Studies

Current Drug Metabolism

Volumn 1, Issue 3, 2000, Pages 215-241

  Thompson, Thomas N ^a  

^a IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ANIMAL; DRUG DESIGN; HUMAN; METABOLISM; PHARMACOLOGY; REVIEW;

ANIMALS; DRUG DESIGN; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY;

EID: 0034329374     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200003339018     Document Type: Article

References (59)

1. Testa, B. and Mayer, J.M. (1990) Acta Pharm. Jugosl., 40, 315-350.
2. Humphrey, M.J. and Smith, D.A. (1992) Xenobiotica, 22(7), 743-755.
3. Chiu, S-H. L. (1993) J. Pharmacol. and Toxicol. Meth., 29(2), 77-83.
4. Smith, D.A. (1994) European Journal of Drug Metabolism & Pharmacokinetics, 19(3), 193-199.
5. Smith, D.A.; Jones, B.C.; Walker, D.K. (1996) Medicinal Research Reviews, 16(3), 243-266.
6. Lin, J.H. and Lu, A.Y.H. (1997) Pharmacol. Rev, 49(4), 403-449.
7. Eddershaw, P.J. and Dickins, M. (1999) Pharmaceutical Sciences-Technology Today, 2(1), 13-19.
8. Foye, W.O. (1990) Principles of Medicinal Chemistry (Foye, W.O., Ed), Lea and Febiger, Philadelphia, 4..
9. Prentis, R.A.; Lis, Y.; and Walker, S.R. (1988) British J. Clin. Pharmacol., 25(3), 387-396.
10. Cashman, J.R. (1996) Drug Discovery Today, 1(5), 209-216.
11. Banerjee, P. and Rosofsky, M. (1997) Scrip Magazine, November, 35-38.
12. Peet, N.P. (1999) Modern Drug Discovery, July/August, 21.
13. Rodrigues, A.D. (1997) Pharmaceutical Res., 14(11), 1504-1510.
14. Rodrigues, A.D., (1998) Med. Chem. Res., 8(7/8), 422-433.
15. Tarbit, M.H.; and Berman, J. (1998) Curr. Opinion in Chemical Biology, 2(3), 411-416.
16. Wrighton, S.A.; Ring, B.J.; and Vandenbranden, M. (1995) Toxicologic Pathology, 23 (2), 199-208.
17. Parkinson, A. (1996) Toxicologic Pathology, 24(1), 45-57.
18. Rane, A.; Wilkinson, G.R.; and Shand, D.G. (1977) J. Pharmacol. Exper. Therap., 200(2), 420-424.
19. Houston, J.B. (1994) Biochemical Pharmaco., 47(9), 1469-1479.
20. Houston, J.B. and Carlile, D.J. (1997) Drug Metabolism Reviews, 29(4), 891-922.
21. Ito, K.; Iwatsubo, T.; Kanamitsu, S.; Nakajima, Y.; Sugiyama, Y. (1998) Annual Review of Pharmacol. Toxicol., 38, 461-99.
22. Iwatsubo, T.; Hirota, N.; Ooie, T.; Suzuki, H.; Shimada, N.; Chiba, K.; Ishizaki, T.; Green, C.E.; Tyson, C.A.; Sugiyama, Y. (1997) Pharmacology & Therapeutics, 73(2): 147-171.
23. Lave, T.; Coassolo, P., and Reigner, B. (1999) Clin. Pharmacokinet, 36(3): 211-231.
24. Obach, R.S.; Baxter, J.G.; Liston, T.E.; Silber, B.M.; Jones, B.C.; MacIntyre, F.; Rance, D.J.; Wastall, P. (1997) J Pharmacol. Exp. Therap., 283(1), 46-58.
25. th ASMS Conference on Mass Spectrometry and Allied Topics, May 31-June 4, 1998, Orlando, FL.
26. Ho, J.; Brown, P.W.; Emary, W.B.; Thompson, T.N.; Toren, P.; Yerino P.P. (1999) Abstracts of the 1999 annual meeting of the American Association of Pharmaceutical Scientists, November 1999, New Orleans, LA.
27. Korfmacher, W.A.; Palmer, C.A.; Nardo, C.; Dunn-Meynell, K.; Grotz, D. Cox, K.; Lin, C-C.; Elicone, C.; Liu, C.; and Duchoslav, E. (1999) Rapid Commun. Mass. Spectrom., 13, 901-907.
28. Korfmacher, W. (2000) Predicting Drug Metabolism, (Rudolph N.S. and Silver, M. eds.) AdvanceTech Monitor, in press.
29. Janusz, M.J.; Durham, S.L.; Hare, C.M.; Geary, J.L.; Mandagare, A.K.; Poole, J.C.; Thompson, T.N.; Xu, D.; Angelastro, M.R.; Burkhart, J.P.; Chen, T.M.; Marquart, A.L.; Peet, N.P.; Hwang, K.K. (1995) J. Pharmacol. Exp. Therap., 275 (3), 1233-1238.
30. Victor, F.; Brown, T.J.; Campanale, K.; Heinz, B.A.; Shipley, L.A.; Su, K.S.; Tang, J.; Vance, L.M.; Spitzer, W.A. (1997) Journal of Medicinal Chemistry, 40(10): 1511-1518.
31. Burkholder, T.P.; Kudlacz, E.M.; Maynard, G.D; Liu, X.G.; Le, T.B.; Webster, M.E.; Horgan, S.W.; Wenstrup, D.L.; Freund, D.W.; Boyer, F.; Bratton, L.; Gross, R.S.; Knippenberg, R.W.; Logan, D.E.; Jones, B.K.; Chen, T.M.; Geary, J.L.; Correll, M.A.; Poole, J.C.; Mandagere, A.K.; Thompson, T.N.; Hwang, K.K. (1997) Bioorganic & Medicinal Chemistry Letters, 7(19): 2531-2536.
32. Lin, N.H.; Gunn, D.E.; Ryther, K.B.; Garvey, D.S.; Donnelly-Roberts, D.L.; Decker, M.W.; Brioni, J.D.; Buckley, M.J.; Rodrigues, A.D.; Marsh, K.G.; Anderson, D.J.; Buccafusco, J.J.; Prendergast, M.A.; Sullivan, J.P.; Williams, M.; Arneric, S.P.; Holladay, M.W. (1997) Journal of Medicinal Chemistry, 40(3): 385-390.
33. Delorme, D.; Ducharme, Y.; Brideau, C.; Chan, C.C.; Chauret, N.; Desmarais, S.; Dube, D. Falgueyret, J.P.; Fortin, R.; Guay, J.; Hamel, P.; Jones, T.R.; Lepine, C.; Li, C.; McAuliffe, M.; McFarlane, C.S.; Nicoll-Griffith, D.A.; Riendeau, D.; Yergey, J.A.; Girard, Y. (1996) Journal of Medicinal Chemistry, 39(20): 3951-3970.
34. Chauret, N.; Li, C.; Ducharme, Y.; Trimble, L.A.; Yergey, J.A.; Ramachandran, C.; Nicoll-Griffith, D.A. (1995) Drug Metabolism & Disposition, 23(1): 65-71.
35. Genin, M.J.; Poel, T.J.; Yagi, Y.; Biles, C.; Althaus, I.; Keiser, B.J.; Kopta, L.A.; Friis, J.M.; Reusser, F.; Adams, W.J.; Olmsted, R.A.; Voorman, R.L.; Thomas, R.C.; Romero, D.L. (1996) Journal of Medicinal Chemistry, 39(26): 5267-5275.
36. Bell, I.M.; Erb, J.M.; Freidinger, R.M.; Gallicchio, S.N.; Guare, J.P.; Guidotti, M.T.; Halpin, R.A.; Hobbs, D.W.; Homnick, C.F.; Kuo, M.S.; Lis, E.V.; Mathre, D.J.; Michelson, S.R.; Pawluczyk, J.M.; Pettibone, D.J.; Reiss, D.R.; Vickers, S.; Williams, P.D.; Woyden, C.J. (1998) Journal of Medicinal Chemistry, 41(12): 2146-2163.
37. Stratford, R.E.; Clay, M.P.; Heinz, B.A.; Kuhfeld, M.T.; Osborne, S.J.; Phillips, D.L.; Sweetana, S.A.; Tebbe, M.J.; Vasudevan, V.; Zornes, L.L.; Lindstrom, T.D. (1999) Journal of Pharmaceutical Sciences, 88(8): 747-753.
38. van Breemen, R.B.; Nikolic, D. and Bolton, J.L. (1998) Drug Metab. Dispos., 26(2): 85-90.
39. Korfmacher, W.A.; Cox, K.A.; Bryant, M.S.; Veals, J.; Ng, K.; Watkins, R. and Lin C-C (1997) Drug Discovery Today, 2(12): 532-537.
40. Dike, L.E.; Guarino, R.; Asa, D.; Timmins, M. (1999) Abstracts of the 9th North American ISSX meeting, October 24-28, Nashville, TN, #178.
41. Jameison, F.; Sanchez, R.I.; Dong, L.; Leland, J.K.; Yost, D.; Martin, M.T. (1996) Anal Chem., 68, 1298-1302.
42. Friedberg, T.; Pritchard, M.P.; Bandera, M.; Hanlon, S.P.; Yao, D.; McLaughlin, L.A.; Ding, S.; Burchell, B.; Wolf, C.R. (1999) Drug Metabolism Reviews, 31(2): 523-44.
43. Riordan, S.; Williams, R. (1997) British Medical Bulletin, 53(4): 730-744.
44. Haseltine, W. A. (1997) Scientific American, March, 92-97.
45. Jones, J.P.; Shou, M.; Korzekwa, K.R. (1996) Advances in Experimental Medicine & Biology, (Snyder, R. et al, eds) Plenum Press, vol 387, pp 355-60.
46. Halpert, J.R.; Domanski, T.L.; Adali, O.; Biagini, C.P.; Cosme, J.; Dierks, E.A.; Johnson, E.F.; Jones, J.P.; Ortiz de Montellano, P.; Philpot, R.M.; Sibbesen, O.; Wyátt, W.K.; Zheng, Z. (1998) Drug Metabolism & Disposition, 26(12): 1223-31.
47. Korzekwa, K.R.; Grogan, J.; DeVito, S.; Jones, J.P. (1996) Advances in Experimental Medicine & Biology, (Snyder, R. et al, eds) Plenum Press, vol 387, pp 361-9.
48. Ekins, S.; Bravi, G.; Wikel, J.H.; Wrighton, S.A. (1999) Journal of Pharmacology & Experimental Therapeutics, 291(1): 424-433.
49. Ekins, S.; Bravi, G.; Binkley, S., Ring, B.J.; Gillespie, J.S.; Wikel, J.H. and Wrighton, S.A.; (1999) Journal of Pharmacology & Experimental Therapeutics, 290(1): 429-438.
50. Ekins S. Bravi G. Ring BJ. Gillespie TA. Gillespie JS. Vandenbranden M. Wrighton SA. Wikel JH. (1999) Journal of Pharmacology & Experimental Therapeutics, 288(1): 21-29.
51. Lewis, D.F.V., Lake, B.G., Dickins, M., Eddershaw, P.J., Tarbit, M.H., and Goldfarb, P.S. Xenobiotica, 29(4): 361-393.
52. de Groot, M.J.; Ackland, M.J.; Horne, V.A.; Alex, A.A.; Jones, B.C. (1999) Journal of Medicinal Chemistry, 42(20): 4062-4070.
53. Halliday, R.C.; Jones, B.C.; Park, B.K.; Smith, D.A. (1997) European Journal of Drug Metabolism & Pharmacokinetics, 22(4): 291-294.
54. Jones, B.C.; Hawksworth, G.; Horne, V.A.; Newlands, A.; Morsman, J.; Tute, M.S.; Smith, D.A. (1996) Drug Metabolism & Disposition, 24(2): 260-266.
55. Erhardt, P.W. (1999) Drug Metabolism: Databases and High-Throughput Testing During Drug Design and Development,(Erhardt, P.W., Ed) IUPAC and Blackwell Publishers.
56. Darvas, F.; Marokhazi, S.; Kormos, P.; Kulkarni, G.; Kalasz, H.; and Papp, A. (1999) Drug Metabolism: Databases and High-Throughput Testing During Drug Design and Development, (Erhardt, P.W., Ed) IUPAC and Blackwell Publishers, p237-270.
57. Klopman, G. and Tu, M. (1999) Drug Metabolism: Databases and High-Throughput Testing During Drug Design and Development, (Erhardt, P.W., Ed) IUPAC and Blackwell Publishers, p271-276.
58. Snyder, R.W. and Grethe, G. (1999) Drug Metabolism: Databases and High-Throughput Testing During Drug Design and Development, (Erhardt, P.W., Ed) IUPAC and Blackwell Publishers, p277-280.
59. Hayward, J. (1999) Drug Metabolism: Databases and High-Throughput Testing During Drug Design and Development, (Erhardt, P.W., Ed) IUPAC and Blackwell Publishers, p281-288.